01—Abstract
Summary
Summary of the 8-K filed February 20, 2025. Cited figures are marked; the original filing is the authoritative source.
Danaher Corporation (DHR) filed an 8-K report on February 20, 2025, announcing two key updates: the appointment of a new independent director and an amendment to its 2007 Omnibus Incentive Plan.
Charles W. Lamanna has joined the Board of Directors and will serve on the Science & Technology Committee. His appointment is considered independent and he will receive standard compensation for non-employee directors, including equity awards.
The second significant development involves an amendment to the Company's 2007 Omnibus Incentive Plan. This amendment enhances benefits for participants whose employment or service terminates due to death or disability.
Specifically, unvested stock options and restricted stock units will now fully vest, and performance stock units (PSUs) will vest at the target level if the termination event occurs before the performance period concludes. These changes aim to provide greater financial security to key personnel and their estates in the event of unforeseen circumstances.
02—Key points
Key Highlights
- Charles W. Lamanna appointed as a new independent director to the Board of Directors, effective February 20, 2025.
- Mr. Lamanna has also been appointed to the Science & Technology Committee.
- The Company's 2007 Omnibus Incentive Plan has been amended and restated.
- The amendment provides for the full vesting of unvested stock options and restricted stock units upon termination due to death or disability.
- For PSUs, participants (or their estates) will receive the target number of shares if death or disability occurs before the performance period ends.
- Director Lamanna will receive compensation consistent with other non-employee directors, including equity awards.
- The filing confirms no undisclosed arrangements or transactions requiring disclosure concerning Mr. Lamanna's appointment.
03—Questions
Frequently Asked Questions
Who is Charles W. Lamanna and why was he appointed to the Board?
Charles W. Lamanna was appointed as a new independent director to Danaher's Board of Directors on February 20, 2025. He will also serve on the Science & Technology Committee. The filing does not specify the exact reasons for his appointment but indicates he is considered independent and will receive standard director compensation.
What are the key changes to the 2007 Omnibus Incentive Plan?
The amendment significantly enhances benefits for employees or service providers whose employment or service is terminated due to death or disability. Key changes include the immediate full vesting of all unvested stock options and restricted stock units. Additionally, performance stock units (PSUs) will vest at the target level if the death or disability occurs before the performance period is completed.
How does this amendment affect current equity award holders?
This amendment provides a substantial benefit to participants by ensuring that unvested equity awards do not lapse if their service ends due to death or disability. It offers greater financial security and certainty for these individuals and their beneficiaries.
Is Mr. Lamanna's appointment or compensation subject to any special disclosures?
No, the filing states that Mr. Lamanna was selected without any undisclosed arrangements or understandings. Furthermore, there are no transactions requiring disclosure under Item 404(a) of Regulation S-K. His compensation as a non-employee director will follow the established policy, including equity awards.
04—Continue